OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2018
(3)
2023
(2)
2025
(1)
2024
(1)
2022
(1)
2014
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618
|
biostudies-literature
Cite
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC12261116
|
biostudies-literature
Cite
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC11581631
|
biostudies-literature
Cite
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC10656670
|
biostudies-literature
Cite
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization.
Not available
S-EPMC10064277
|
biostudies-literature
Cite
Prediction of disability-free survival in healthy older people.
Not available
S-EPMC9213595
|
biostudies-literature
Cite
Effect of Aspirin on Disability-free Survival in the Healthy Elderly.
Not available
S-EPMC6426126
|
biostudies-literature
Cite
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.
Not available
S-EPMC6433466
|
biostudies-literature
Cite
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
Not available
S-EPMC6289056
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets